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of a successful therapy is also shown.
Left Bundle Branch Block
One hundred years ago, Eppinger and Tothberger reported
distinctive changes in QRS morphology after the destruction
of only a small region in the interventricular septum in
canine hearts [4]. Since the esophageal-to-rectal leads in
the dogs were directly extrapolated to leads II and III in
human patients, LBBB too was erroneously diagnosed as
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Abstract Cardiac resynchronization therapy (CRT) aims to
treat selected heart failure patients suffering from conduc-
tion abnormalities with left bundle branch block (LBBB) as
the culprit disease. LBBB remained largely underinvesti-
gated until it became apparent that the amount of response
to CRT was heterogeneous and that the therapy and under-
lying pathology were thus incompletely understood. In this
review, current knowledge concerning activation in LBBB
and during biventricular pacing will be explored and applied
to current CRT practice, highlighting novel ways to better
measure and treat the electrical substrate.
Keywords Left bundle branch block . Cardiac
resynchronization therapy . Electrical mapping
Introduction
In the past decade, cardiac resynchronization therapy (CRT)
has become an important treatment option for symptomatic
heart failure patients with reduced left ventricular (LV)
ejection fraction and abnormal QRS duration mostly in the
form of left bundle branch block (LBBB). Until recently,
little was known about the pathophysiology of the conduc-
tion disease and its adverse effects on ventricular contractil-
ity. Large clinical trials have shown that CRT benefits most
patients but approximately one third of patients to not show
clinical or echocardiographic response. Furthermore, further
analysis of these studies show that the amount of responders
was considerably higher in patients with LBBB as compared
with patients without this conduction disease [1]. These
aspects have revamped major interest in LBBB. This inter-
est is further enforced by the difficulties of echocardiograph-
ic mechanical dyssynchrony measurements to adequately
predict CRT response. Insight in electrical activation during
LBBB and ventricular pacing during CRT has steadily in-
creased over the last few years. LBBB appears to be the
hallmark conduction disease that is treatable by CRT inde-
pendently from etiology, as evidenced by efficacy of CRT in
canine hearts with isolated LBBB and in CRT patients with
LBBB compared to CRT patients with other conduction
disorders [2, 3]. It is also becoming increasingly apparent
that the site of LV stimulation, the electrical and mechanical
activation patterns, and the presence of little or no scar are
all critical for CRT success. In this paper, electrical and
mechanical activation patterns during LBBB and CRT are
discussed. Why these aspects are important for the delivery
right bundle branch block (RBBB) and vice versa for
25 years. This misinterpretation illustrates the fact that the
conduction disease was not considered important, and
LBBB was solely considered a sign of poor prognosis. Only
later it was discovered that most patients with LBBB who
died shortly after diagnosis died of underlying heart disease
and that the conduction disease on its own was not as
dangerous as previously believed. It was not until 1972 that
the anatomy of the left bundle branch (LBB) was described
in more detail. A histopathological study in human patients
without known cardiac disease, showed that the LBB is a
continuation of the His bundle and initiates between the
non-coronary and right-coronary aortic cusps. It runs as a
6 to 10-mm wide ribbon-like structure under the septal
endocardium in inferior and anterior directions [5]. The
fibers of the LBB fibers then separate to form fasciculi into
anterior, posterior, and often septal radiations in heteroge-
neous patterns. Ultimately, the peripheral Purkinje fibers are
coupled with individual (sub)endocardial myocardial cells
which allows fast depolarization of the LV [6]. In isolated
human hearts with an intact LBB, extensive electrical map-
ping showed up to three LV endocardial breakthrough sites
which resulted in a rapid electrical activation of the LV [7].
Investigation of the electrical activation during LBBB
can be performed in patients but is limited by the presence
of comorbidities and the lack of knowledge concerning the
duration and extent of the lesion (or lesions). Animal models
can be used to specifically investigate the effects of isolated
LBBB as discussed more extensively elsewhere in this
edition [8]. Examples of three-dimensional activation time
maps in a canine heart before and after induction of LBBB
are shown in Fig. 1. In LBBB, onset of electrical activation
occurs inside the right ventricle and the electrical wavefront
then slowly propagates through the interventricular septum
towards the lateral wall of the LV [9]. As is also shown in a
schematic representation of transmural conduction during
normal and LBBB conduction in humans (Fig. 2), LBBB
reverses transseptal activation and causes large changes in
QRS morphology and duration. Electrocardiographic imag-
ing (ECGi, a novel technique that extracts estimated epicar-
dial activation sequence from body surface maps) shows
multiple epicardial conduction patterns in CRT candidates
with LBBB of which an example is shown in Fig. 3 [10].
The LV endocardial activation sequence during LBBB has
also proven to be heterogeneous in heart failure patients as
shown by conventional point-by-point technique or three-
dimensional electroanatomical reconstruction contact (Carto)
and non-contact mapping (EnSite) technique. These studies
have shown that in LBBB patients with heart failure, LV
endocardial breakthrough is heterogenous and may occur at
different septal regions [11, 12]. In some patients, break-
through occurred in the mid-septal region, which could sug-
gest activation by slow conduction through the LBB, in some
others, via right-to-left transseptal activation as observed in
dog models [11]. Narula reported in 1977 that by distal His-
Bundle pacing in the right ventricle, he was able to abolish the
electrocardiographic signs of LBBB in 25 patients, thereby
“curing” the conduction disease. In these LBBB patients, the
lesions were apparently located proximal in the rapid conduc-
tion system, just below the AV node [13].
The varying conduction patterns could thus be caused by
one or more of the following aspects: (1) the varying struc-
ture of the LBB, (2) variability in the location of the LBB
“block”, being either a proximal lesion or a more distal and
diffuse disease, (3) LV hypertrophy and fibrosis as associated
cellular uncoupling can result in increasing QRS duration and
left bundle branch block
0 20 40 60 80 100 120(ms)
normal conduction
Fig. 1 Typical examples of 3D electrical activation in canine hearts
during normal conduction (left panel) and after creation of left bundle
branch block (right panel). Each electrical activation map is recon-
structed using a single-beat recording of simultaneous epicardial and
endocardial electrical mapping. Epicardial potentials were derived
using electrode bands placed around the heart, containing over 100
contact electrodes while the LV endocardium was mapped using
custom-made plunge electrodes [63]. Early activated regions are indi-
cated by a red color (close to 0 ms) and late activation regions are
indicated by a dark blue color (over 100 ms), see color bar. Repro-
duced with permission [8]
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a LBBB-like QRS morphology [14]. The heterogeneous acti-
vation patterns seen in heart failure patients with LBBBmight
in part explain why CRT leads to varying amount of response.
In addition, mentioned data accentuate the need for patient
tailored therapy by carefully selecting the site of pacing and
pacing settings.
Electrophysiological Evaluation of the CRT Candidate
The key clinical investigation to detect and evaluate the
extent of ventricular conduction delay remains the surface
electrocardiogram. To diagnose LBBB in patients, specific
ECG criteria exist in addition to QRS width ≥120 ms such
as a broad notched or slurred R wave in leads I, aVL, V5,
and V6, an occasional RS pattern in V5 and V6 attributed to
displaced transition of QRS complex, and absent q waves in
leads I, V5, and V6 (in the absence of a large anterior-apical
infarction) [15]. Note that although scar in the septum
causes q waves in V1 to V3 when normal conduction is
present, the same scar causes large R waves in V1 to V3 in
the presence of LBBB because of unopposed electrical
forces in the RV free wall [16]. When these criteria are not
met, it is likely that patients have RBBB or slowed conduc-
tion by LV hypertrophy. Some heart failure patients with
RBBB have been shown to have LV conduction delay
similar to LBBB patients [17] but large trials have failed
to show CRT response in these patients [18–20]. Recently, it
has been shown that patients with QRS duration >150 ms
and LBBB morphology show the highest response rate in
large multicenter trials [21, 22]. It should be mentioned
however that in most CRT trials, patients were required to
have QRS duration of at least 120 ms, and approximately one
third of these patients did not have LBBB [3, 20]. On top of
that, one third of patients diagnosed with LBBB by conven-
tional electrocardiographic criteria may not have true com-
plete LBBB but likely have a combination of left ventricular
hypertrophy and left anterior fascicular block [9, 23]. A recent
electrical mapping study showed that “true LBBB” was only
seen in patients with a QRS duration exceeding 140 ms [24].
normal conduction
left bundle branch block
Fig. 2 Timing of electrical activation (depolarization) wavefronts in
normal conduction and during LBBB shown in sagittal view. For
reference, two QRS-T waveforms are shown in their anatomic loca-
tions (V3 on the chest and aVF inferiorly). Electrical activation starts at
the small arrows and spreads in a wavefront with each colored line
representing successive 10 ms. In normal conduction, activation begins
within both the LV and RV endocardium. In LBBB, activation only
begins in the RVand must proceed through the septum before reaching
the LV endocardium. Reproduced with permission [64]
Fig. 3 Epicardial isochrone
maps during native rhythm in a
patient with LBBB. Left anterior
escending (LAD) coronary artery
is shown and the approximate
valve region is covered by gray.
Earliest and latest ventricular
activation times (in milliseconds)
are indicated by framed numbers.
Activation times are given with
respect to QRS onset. QRSd
QRS duration. Reproduced with
permission [10]
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In the past decade, most efforts focused on finding dys-
synchrony parameters to predict CRT response were based
on echocardiography, which are discussed later in this re-
view. Interestingly, recent studies have revamped the inter-
est in using the surface ECG for exactly that purpose. An
example is the PROSPECT trial where multiple echocardi-
ography derived dyssynchrony parameters were investigat-
ed, followed by a sub-study where various ECG parameters
were tested [22, 25]. In fact, LBBB morphology was the
only parameter that was predictive for both volumetric and
clinical response after 6 months (defined by LVend-systolic
volume reduction of ≥15% and improvement in Clinical
Composite Score, respectively). In addition, a broad QRS
complex during single-site LV pacing was predictive of
failure of volumetric response (OR00.86 per 10 ms incre-
ment). In non-ischemic patients, an LV paced QRS width
of ≤200 ms was five times more likely to be associated with
a positive response than having a LV paced QRS width
greater than 200 ms, while no such difference was found
in ischemic patients. The authors of this article postulate that
LV paced QRS width may be an indirect method of identi-
fying a region near scar or an area of poor conduction.
Sweeney et al. [26] carefully inspected standard 12-lead
electrocardiograms of 202 LBBB patients indicated for
CRT. Based on the comparisons of baseline and post-
implant electrocardiograms the authors introduced new
measurements, which predicted CRT response (defined as
at least 10% reduction in end-systolic volume as derived by
echocardiography at 6 months). A notch, which occurred
after 40 ms of QRS onset, was regarded as the transition
from RV to LV depolarization and the time difference be-
tween this notch and the end of QRS was indicated as the
LV activation time (LVATmax). QRS duration was weakly
associated with reverse remodeling probability and this re-
lationship was replaced by LVATmax in the multivariable
model. A longer LVATmax at baseline was predictive of
CRT response (OR 1.30 for each 10 ms increase up to
125, p00.001). The Selvester QRS score was used to quan-
tify LV scar and a higher score was detrimental to volumet-
ric response (OR 0.49 for each 1 point increase from 0 to 4,
p00.002) [24]. The appearance of anterior forces in the
precordial leads after implantation (change in R amplitude
in V1 and V2 in expected direction) was also predictive of
CRT response. An alternative method to estimate LV elec-
trical asynchrony is by calculating the delay between QRS
onset and LV lead depolarization. Varma found in heart
failure patients that this delay exceeded 100 ms in 87% of
LBBB patients as compared to 45% of RBBB patients, even
though there was no difference in QRS duration [27]. Singh
et al. [28] showed that CRT patients with a reduced LV lead
electrical delay (<50% of the QRS duration) before biven-
tricular pacing was associated with worse clinical outcome
at 12 months.
Studies investigating electrocardiography beyond surface
ECG or pacemaker lead electrograms are even scarcer be-
cause evaluation of cardiac electrical activation sequence by
catheter mapping in CRT candidates is time-consuming,
cumbersome, and not without risk. Lines of conduction
block are seen in most LBBB patients as shown by endo-
cardial (EnSite) and epicardial (ECGi) non-contact mapping
studies [10, 12]. The implications of these lines of block
have been investigated in a small observational study where
non-contact mapping was performed in 23 CRT candidates
[29]. Twelve of the 18 patients who had lines of conduction
block before implantation were volumetric CRT responders
at 3 months as opposed to one of the eight patients who had
homogeneous endocardial conduction (p00.01). This study
confirmed that the benefit of CRT is more dependent on
specific LV activation patterns rather than on total LV acti-
vation time, which could explain why LVATmax beyond
125 ms, and in some studies QRS duration, are poor indi-
vidual predictors of response [26, 30].
Mechanical Evaluation of the CRT Candidate
Although the underlying pathophysiological mechanisms
of how LBBB induces left ventricular dysfunction re-
main to be clarified, LBBB yields a disturbance of
mechanical coordination between the different regions
of the left ventricular walls, especially between septum
and lateral wall. Moreover, the extremely variable and
relatively unpredictable nature of response to CRT
remains puzzling. Transthoracic echocardiography repre-
sents a non-invasive method that has been used to
address some of these issues. The first measurements
such as interventricular mechanical delay, septal poste-
rior wall motion delay and pulsed-wave, color-coded
tissue Doppler imaging were all measures of myocardial
regional mechanical delay in patients with heart failure
and ventricular conduction delays (mostly LBBB, Table 1)
[25, 31, 32]. The very promising initial findings derived
mainly from single center studies, showing excellent
predictive value of these parameters were offset by the
more recent results of the PROSPECT and J-CRT trials
[25, 33]. In these trials, area under receiver-operating
characteristics curve (ROC) for positive clinical or vol-
ume response after CRT was ≤0.62. Possible reasons
accounting for the shortcomings of these measures in-
clude inability to discern passive from active wall
movements, limited 2-D plane and operator dependency.
However, some studies showed that timing parameters
as determined by the gold-standard deformation tech-
nique of MRI tagging were also not able to predict CRT
response, indicating that timing parameters may have intrinsic
limitations [34].
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Further development of echocardiographic methodol-
ogies coupled with the advances in the field of cardiac
magnetic resonance have provided greater depth of un-
derstanding in the complex mechanical myocardial wall
behavior during LBBB. Some additional aspects of the
physiology of myocardium wall motion during LBBB
should be taken into account. Myocardial fiber spatial
disposition in three different layers cause the mechanical
contractile movement to be nonsymmetrical and in dif-
ferent directions. Myocardial contractile thickening has
been observed to be longitudinal, circumferential, and
radial, thus conferring a movement of torsion during
systole [35]. In the context of important ventricular
conduction delay such as LBBB, myocardial regional
motion is characterized by complex and multiphasic
mechanical behavior [36]. It follows therefore that
measures evaluating global wall motion or myocardial
efficiency in all three different perspectives, rather than
regional two-dimensional measures, may be more suit-
able to characterize contractile mechanics during LBBB.
With these notions, echocardiography has manifested a
new drive in the last few years with the emergence of
new dyssynchrony measures. The most widely used
technique for the detection of myocardial deformation
by discriminating active from passive wall motion is
speckle tracking imaging (STI) strain. By considering
the sum of the difference between peak and end-systolic
strain across 16 segments (strain delay index), Lim et
al. [37] found that longitudinal strain by STI in HF
patients with ventricular conduction delay was predic-
tive of CRT response. Another study by Klimusina et al.
[38] utilized segmental peak myocardial strain in heart
failure patients derived from speckle tracking and
showed that heart failure patients with intraventricular
conduction delay presented heterogeneity in longitudinal
and radial strain distributions, with amplitudes being partic-
ularly low in the septum and higher in the lateral and posterior
walls. Based on the Speckle Tracking and Resynchronization
Study (STAR) for prediction of volume response after CRT,
ROC for circumferential and longitudinal speckle-tracking
was 0.59 and 0.57, respectively, whereas that of radial and
transverse strain was superior (0.79 and 0.75, respectively). It
should be mentioned however that a proportion of patients
without detected dyssynchrony nevertheless showed reverse
remodeling after CRT; these patients were most likely to
present a wide QRS and non-ischemic heart failure etiology
[39]. One of the most promising echocardiographic indices is
Septal Rebound Stretch (SRSsept). SRSsept is defined as
systolic stretch occurring after initial shortening in the early
activated septum. De Boeck et al. [40] showed that SRSsept
strongly correlated with an increase in LV ejection fraction
after CRT as well as a reduction in LVESV and brain natri-
uretic peptide. SRSsept predicted a 15% reduction in LVESV
with an AUC of 0.81.
Cardiac magnetic resonance is a high resolution image
modality which allows complex and global assessment not
only of cardiac morphology, but also function. Indeed, this
imaging modality has emerged to become the “gold-stan-
dard” for the characterization of myocardial contractile be-
havior. By using MRI tagging, time plots of strain are
generated for each segment in each short-axis slice, and
the circumferential uniformity ratio estimate (CURE) is
Table 1 Most accurate (sensitivity>80%, specificity>75%, or ROC>0.80) measurements to detect mechanical discoordination caused by
ventricular conduction delay, such as LBBB, in CRT candidates
Author Parameter Design Patients (n) Ischemic
etiology (%)
Follow-up
(months)
Cut-off
Echocardiographic measurements of regional delay
Soliman (2009) [57] 3D-SDI SC, obs 90 51 1 >10%
Bax (2004) [58] Ts-4 SC, obs 80 55 6 65 ms
Yu (2003) [59] Ts-SDI2 SC, obs 30 40 3 32.6 ms
Suffoletto (2006) [60] 2D-RS SC, obs 50 62 8 130 ms
Echocardiographic measurements of mechanical discoordination and inefficiency
Jansen (2007) [61] Shuffle and septal motion SC, obs 53 49 3 NA
Buss (2009) [62] EPI SC, obs 42 43 6–8 59%
De Boeck (2009) [40] SRSsept SC, obs 62 44 6.5 4.7%
Lim (2008) [37] Strain-delay SC, obs 62 35 3 25%
Cardiac magnetic resonance measures of dyssynchrony
Bilchick (2008) [42] CURE index SC, obs, control 20 40 / < 0.75
2d-RS speckle tracking radial strain; 3D-SDI standard deviation of 16 time-volume peaks; CURE index circumferential uniformity ratio estimate;
EPI echocardiographic phase imaging; obs observational; SC single center; SRS Sept systolic rebound stretch in the septum; Ts-4 maximal velocity
delay between four basal segments; Ts-SD12 standard deviation of velocity peaks in 12 basal and midventricular segments
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calculated [41]. This ratio considers “0” most dyssynchro-
nous and “1” absence of dyssynchrony. A CURE cut-off
of <0.75 accurately predicts symptomatic response after
CRT [42]. An important additional aspect is that CURE uses
information from the full cardiac cycle and not only time-to-
peak. The paucity of consistent prospective, multicenter data
on echocardiographic and CMR parameters estimating LV
dyssynchrony during LBBB, along with the expensive,
time-consuming, and knowledge-intensive nature of these
investigations, have limited the diffusion of such technolo-
gies to select the adequate CRT candidate.
CRT in the Ischemic Dyssynchronous Heart
Most studies show that CRT response is higher in non-
ischemic patients [43, 44]. A possible mechanism lies in
modification of the electrical substrate. According to this idea,
the extent of resynchronization would be limited as a result of
slow-conducting or non-conducting regions. This would
mean that a good response to CRT not only requires clear
conduction disease, but also the capability to properly
resynchronize the heart. Figure 4 shows examples of how an
LAD or LCX infarction can influence electrical resynchroni-
zation in dogs with LBBB. An important feature in this regard
is the site of pacing as pacing in the vicinity of scar tissue can
compromise conduction. In canine hearts with LBBB and
transmural infarction, pacing away from the infarcted regions
resulted in a similar CRT response as in non-infarcted canine
LBBB hearts [45].
In line with the pre-clinical data, clinical response after
CRT is assumed to involve three key factors: lead position
(in relation to area of greatest delay or vicinity to scar tissue),
the presence of discoordinate and inefficient area of myocar-
dial contractility, and quantity/degree of scarred tissue. How-
ever, rapid, effective, and integrated assessment of these
features in the diagnostic build-up of patients considered for
CRT, remains an unresolved challenge. Furthermore, the pres-
ent literature offering aid remains scanty. Some important
single center studies have shown how measures derived from
CMR may be of great use. The relation between scar and left
ventricular lead deployment has been unveiled using CMR
late gadolinium enhancement [46, 47]. This method, besides
emphasizing how scar size and transmurality were associated
to a dismal prognosis after CRT, also showed how pacing scar
localized in a postero-lateral area reduces CRT response rate.
Another CMR study, which examined the relationship between
left ventricular myocardial dyssynchrony (circumferential uni-
formity ratio estimate derived from myocardial tagging—MT)
and scar location (delayed enhancement—DE), found that
functional class improvement after CRT was predicted by
MT and that DE offered further predictive value [42]. Though
the data are limited, there is no doubt that the development of
integrated measures derived from CMRmay be of great use to
improve selection eligible for CRT (see Table 1).
Worthy to mention is the study by Delgado et al. [48]
who have addressed the relative influence of ventricular
dyssynchrony, left ventricular lead position, and myocardial
scar on the long-term prognosis of patients treated with
LBBB LBBB +LAD infarction
LBBB +
LCX infarction
Intrinsic
conduction
CRT
Fig. 4 3D reconstruction of electrical activation times of the LV and
the RV during intrinsic conduction (LBBB) and BiV pacing (at the RV
apex and basal-lateral LV wall) in representative hearts with LBBB
(left), LBBB with LAD infarction (middle), and LBBB with LCX
infarction (right). Reproduced with permission [65]
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CRT. Through the use of two-dimensional speckle tracking
radial strain imaging LV dyssynchrony (difference between
the earliest and latest of six segments) was measured and the
regions of scar were identified (considered segments with
peak radial strain value <16.5%). After CRT, the influence
of LV lead position was assessed retrospectively radiograph-
ically and placed in relation to the segment of greatest delay
or the area of scar. The investigators found that the inde-
pendent predictors of unfavorable prognosis after CRT were
discordant LV lead position with respect to the radial seg-
ment of greatest delay and the presence of myocardial scar
at the level of the pacing lead. A significantly better prog-
nosis was found in patients with a substantial time delay
between the antero-septal and posterior segments
(≥130 ms). In spite of the methodological limits of the study,
i.e., only radial strain to assess left ventricular dyssynchrony
[49] and simple retrospective radiographical assessment of
lead position, this study is the first which demonstrates how
lead position, electro-mechanical delay, and presence of scar
are inextricably linked and impact on the prognosis of CRT
patients. Leyva et al. [47] also showed that LV lead position
inside the scar region results in a fivefold risk of pump
failure and sudden cardiac death as compared to patients
with no scar and patients with scar, but LV lead positioned
elsewhere combined. Besides avoiding scar tissue, the posi-
tion of the LV could also be improved by moving from the
epicardium (epicardial implant or coronary sinus) to the
endocardium. Under physiological conditions, excitation of
the LV initiates at the endocardium [7] while in CRT, the LV
is most often paced at the epicardial surface. As discussed,
conventional CRT can resynchronize the heart but not to
(near) normal conditions. In canine LBBB hearts with myo-
cardial infarction, endocardial LV pacing during CRT con-
sistently improved systolic LV pump function, reduced
electrical dyssynchrony and decreased dispersion of repo-
larization, as compared to epicardial LV pacing at the same
site (Fig. 5) [50]. Additionally, the hemodynamic effects for
endocardial sites were less dependent on location and AV-
delay than epicardial sites. The added benefit of endocar-
dial CRT was also seen in dogs with heart failure
(induced by tachypacing) [50] and in dogs with isolated
LBBB [51]. Support for these experimental findings
come from studies by Spragg et al. [52] in seven ICM
patients where LV endocardial and epicardial pacing at
immediately transmural sites gave equivalent LV dP/dtmax
values. However, LV dP/dtmax at best LV endocardial sites
was greater than conventional CRT. Given individual varia-
tions in etiology, severity, patterns of delayed ventricular
activation, location of regions of scar, and extent of mitral
regurgitation in heart failure, it seems indeed unlikely that one
pacing site will “fit all”. Individual tailoring of endocardial
CRT by searching the optimal pacing site within the endocar-
dium is warranted. LV endocardial pacing in humans can be
established through an atrial transseptal approach [53, 54] or a
left transapical approach can be used [55]. In the future,
wireless endocardial LV stimulation [56] might become the
most feasible approach.
Conclusions
Left bundle branch block results in asynchronous elec-
trical activation, which can be largely reversed by CRT,
thus conferring favorable clinical effects. It is imperative
that correct electrical substrate, preferably in the form of
true left bundle branch block, coexists with adequate
morphological and anatomical conditions to allow ade-
quate CRT delivery. In the future, integrated multi-
modality imaging presents the central and challenging
task to transfer pre-clinical knowledge into clinical prac-
tice, hence further defining the complex mechanical and
functional effects of LBBB. On the other hand, with the
aid of endocardial LV pacing, with- or without RV pacing,
patient-specific tailoring of CRT will likely increase therapy
success.
100ms
80
60
40
20
0
infarcted
region
epicardial CRT endocardial CRTFig. 5 Typical examples of 3Delectrical activation in canine
hearts with chronic LBBB and
transmural myocardial
infarction during CRT with
epicardial LV pacing (left
panel) and endocardial LV
pacing (right panel).
Reproduced with
permission [1]
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